Evidence map›Paper›PMID 38509181›Full record

ArticleScientific reports2024

Estimating actual SARS-CoV-2 infections from secondary data.

Wolfgang Rauch, Hannes Schenk, Nikolaus Rauch, Matthias Harders, Herbert Oberacher, Heribert Insam, Rudolf Markt, Norbert Kreuzinger

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wolfgang RauchUnit of Environmental Engineering, Department of Infrastructure, University of Innsbruck, Technikerstrasse 13, 6020, Innsbruck, Austria. wolfgang.rauch@uibk.ac.at.
Hannes SchenkUnit of Environmental Engineering, Department of Infrastructure, University of Innsbruck, Technikerstrasse 13, 6020, Innsbruck, Austria.
Nikolaus RauchInteractive Graphics and Simulation Group, University of Innsbruck, Innsbruck, Austria.
Matthias HardersInteractive Graphics and Simulation Group, University of Innsbruck, Innsbruck, Austria.
Herbert OberacherInstitute of Legal Medicine and Core Facility Metabolomics, Medical University of Innsbruck, Innsbruck, Austria.
Heribert InsamDepartment of Microbiology, University of Innsbruck, Technikerstrasse 25, 6020, Innsbruck, Austria.
Rudolf MarktDepartment of Health Sciences and Social Work, Carinthia University of Applied Sciences, Villach, Austria.
Norbert KreuzingerInstitute of Water Quality and Resource Management, Technical University Vienna, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eminent in pandemic management is accurate information on infection dynamics to plan for timely installation of control measures and vaccination campaigns. Despite huge efforts in diagnostic testing of individuals, the underestimation of the actual number of SARS-CoV-2 infections remains significant due to the large number of undocumented cases. In this paper we demonstrate and compare three methods to estimate the dynamics of true infections based on secondary data i.e., (a) test positivity, (b) infection fatality and (c) wastewater monitoring. The concept is tested with Austrian data on a national basis for the period of April 2020 to December 2022. Further, we use the results of prevalence studies from the same period to generate (upper and lower bounds of) credible intervals for true infections for four data points. Model parameters are subsequently estimated by applying Approximate Bayesian Computation-rejection sampling and Genetic Algorithms. The method is then validated for the case study Vienna. We find that all three methods yield fairly similar results for estimating the true number of infections, which supports the idea that all three datasets contain similar baseline information. None of them is considered superior, as their advantages and shortcomings depend on the specific case study at hand.

Indexed as

COVID-19Bayes TheoremHumansPandemicsSARS-CoV-2

Identifiers

PMID38509181
PMCPMC10954653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.